Citadel Advisors’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.9K | Buy |
+17,095
| New | +$29.9K | ﹤0.01% | 5570 |
|
|
2024
Q4 | – | Sell |
-10,305
| Closed | -$27.8K | – | 6660 |
|
|
2024
Q3 | $27.8K | Buy |
+10,305
| New | +$27.8K | ﹤0.01% | 5267 |
|
|
2024
Q1 | – | Sell |
-1,672
| Closed | -$11.5K | – | 6748 |
|
|
2023
Q4 | $11.5K | Buy |
+1,672
| New | +$11.5K | ﹤0.01% | 5512 |
|
|
2023
Q2 | – | Sell |
-2,840
| Closed | -$12.5K | – | 6388 |
|
|
2023
Q1 | $12.5K | Sell |
2,840
-8,082
| -74% | -$35.6K | ﹤0.01% | 5484 |
|
|
2022
Q4 | $64.4K | Buy |
10,922
+6,906
| +172% | +$40.7K | ﹤0.01% | 5189 |
|
|
2022
Q3 | $28K | Buy |
+4,016
| New | +$28K | ﹤0.01% | 5467 |
|
|
2022
Q1 | – | Sell |
-2,423
| Closed | -$189K | – | 7010 |
|
|
2021
Q4 | $189K | Sell |
2,423
-765
| -24% | -$59.7K | ﹤0.01% | 5518 |
|
|
2021
Q3 | $321K | Sell |
3,188
-642
| -17% | -$64.6K | ﹤0.01% | 4966 |
|
|
2021
Q2 | $382K | Sell |
3,830
-777
| -17% | -$77.5K | ﹤0.01% | 4971 |
|
|
2021
Q1 | $452K | Buy |
+4,607
| New | +$452K | ﹤0.01% | 4660 |
|